Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients

Ozcan O. U., Er H. A., GÜLEÇ H. S., Ustun E. E., GEREDE ULUDAĞ D. M., Goksuluk H., ...Daha Fazla

CLINICAL CARDIOLOGY, cilt.38, sa.3, ss.150-156, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1002/clc.22364
  • Dergi Adı: CLINICAL CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.150-156
  • Ankara Üniversitesi Adresli: Evet

Özet

BackgroundIdentifying patients who are vulnerable to development of contrast-induced nephropathy (CIN) is essential because of its association with prolonged hospitalization, increased cost, and increased in-hospital and long-term mortality rates.